RJA
AVNS

Raymond James & Associates’s Avanos Medical AVNS Stock Holding History

Raymond James & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,952
Closed -$260K – 3666
2019
Q3 		$260K Buy
6,952
+829
+14% +$31.6K ﹤0.01% 3094
2019
Q2 		$267K Buy
6,123
+563
+10% +$24.1K ﹤0.01% 3075
2019
Q1 		$237K Sell
5,560
-946
-15% -$42.4K ﹤0.01% 3122
2018
Q4 		$291K Sell
6,506
-287
-4% -$15K ﹤0.01% 2887
2018
Q3 		$465K Buy
6,793
+551
+9% +$35.5K ﹤0.01% 2752
2018
Q2 		$357K Buy
6,242
+274
+5% +$14.5K ﹤0.01% 2908
2018
Q1 		$275K Buy
+5,968
New +$283K ﹤0.01% 2937
2017
Q4 		– Sell
-6,751
Closed -$304K – 3429
2017
Q3 		$304K Sell
6,751
-326
-5% -$13.9K ﹤0.01% 2785
2017
Q2 		$278K Sell
7,077
-188
-3% -$7.1K ﹤0.01% 2764
2017
Q1 		$277K Sell
7,265
-381
-5% -$14.8K ﹤0.01% 2737
2016
Q4 		$283K Sell
7,646
-5,445
-42% -$195K ﹤0.01% 2656
2016
Q3 		$454K Buy
13,091
+176
+1% +$6.16K ﹤0.01% 2352
2016
Q2 		$420K Sell
12,915
-3,155
-20% -$96.6K ﹤0.01% 2199
2016
Q1 		$462K Buy
+16,070
New +$428K ﹤0.01% 2083
2015
Q3 		– Sell
-11,822
Closed -$479K – 2267
2015
Q2 		$479K Sell
11,822
-26,648
-69% -$1.2M ﹤0.01% 2110
2015
Q1 		$1.89M Buy
38,470
+5,637
+17% +$261K 0.01% 1270
2014
Q4 		$1.49M Buy
+32,833
New +$1.29M 0.01% 1325

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Raymond James & Associates's AVNS Position: Q4 2019 in Review

Raymond James & Associates sold out of Avanos Medical (AVNS) in Q4 2019, closing a stake of 6,952 shares — an estimated $260K sold.

Raymond James & Associates first reported a position in AVNS in Q4 2014 and held it in 17 quarters. The position peaked at $1.89M in Q1 2015. 293 funds tracked by Wall St. Rank hold AVNS as of Q4 2019.

  • Raymond James & Associates reported no remaining Avanos Medical position as of Q4 2019 after selling out during the quarter.
  • Raymond James & Associates sold 6,952 Avanos Medical shares in Q4 2019, an estimated $260K.
  • Raymond James & Associates first reported a position in Avanos Medical in Q4 2014 and held it in 17 quarters.
  • Raymond James & Associates's Avanos Medical position peaked at $1.89M in Q1 2015.
  • 293 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2019.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.